Closed
[Call for Topics] 2023 Guangdong Key Area R&D Scheme for Biomedicine and Health, High-end Medical Equipment, Lingnan TCM Modernization and its Key Processing Technologies and Equipment 2023年度广东省重点领域研发计划“生物医药与健康”“高端医疗器械”“岭南中医药现代化及关键技术装备”重大重点专项指南建议征集通知
  • Call for Proposal Announcement

    广东省科学技术厅关于征集2023年度省重点领域研发计划“生物医药与健康”“高端医疗器械”“岭南中医药现代化及关键技术装备”重大重点专项指南建议的通知

  • Basic information

    • Sponsor:

      Department of Science and Technology of Guangdong Province

      广东省科技厅

    • Research Areas:

      Biomedicine and Health, High-end Medical Equipment, Lingnan TCM Modernization and its Key Processing Technologies and Equipment

      生物医药与健康、高端医疗器械、岭南中医药现代化及关键技术装备

    • Project Funding:

      5-10 million RMB

      500-1000万元

    • Project Duration:

      Not specified

      未明确

    • Internal Deadline:

      17:00 12 April 2023

      2023年04月12日 17:00

    • External Deadline:

      14 April 2023

      2023年04月14日

    • Internal Deadline:

      2023-04-12 17:00:00

    • External Deadline:

      2023-04-14 23:59:59

  • Synopsis of the Scheme 项目简介

    Guangdong Key Area R&D Scheme was established by the People's Government of Guangdong Province, focusing on nine key research areas, including new generation of information technology, high-end equipment manufacturing, green and low-carbon technology, biomedicine, digital economy, new materials, marine economy, modern seed industry and precision agriculture, and modern engineering technology. The scheme is set to encourage researchers to strive to make breakthroughs in a number of cutting-edge, leading and "bottleneck" technologies to realize the autonomous control of key technologies, key components and major equipment.

    广东省重点领域研发计划由广东省人民政府批准设立,聚焦九大重点领域(新一代信息技术、高端装备制造、绿色低碳、生物医药、数字经济、新材料、海洋经济、现代种业和精准农业、现代工程技术)开展关键核心技术攻关,力争突破一批前沿性、引领性和“卡脖子”技术,实现关键核心技术、关键零部件和重大装备的自主可控。

    This year, the call for topics mainly focuses on the following areas:

    • Major project of “Bio-medicine and health”: biology and information fusion (BT and IT fusion), biologicals, pharmaceutical chemicals, pharmaceutic adjuvant and materials, green pharmaceutical, construction of bio-medicine public technical service platform.
    • Major project of “medical apparatus and instruments”: in vitro diagnosis(IVD) equipment and reagents, biomedical materials, active and passive implantable medical devices, diagnostic and therapeutic equipment, health care and rehabilitation equipment.
    • Major project of “Lingnan TCM modernization and its key processing technologies and equipment”: diagnosis and treatment of dominant diseases of TCM, Chinese medicine new drugs development and product development, key TCM equipment R&D.

    本次征集方向主要包括:

    • “生物医药与健康”重大专项:生物与信息融合(BT与IT融合)、生物制剂、化学药、药用辅料与材料、绿色制药、生物医药公共技术服务平台建设等。
    • “高端医疗器械”重点专项:体外诊断设备与试剂、生物医用材料、有源或无源植介入器械、诊断治疗装备、保健康复装备等。
    • “岭南中医药现代化及关键技术装备”重点专项:中医药优势病种诊断治疗、中药新药创制与产品研发、中医药关键装备研发。

    Submission 提交方式

    Faculty members should fill in the proposed topics template and send it to the Research Department Contact Alan Meng (Email: alanxmeng@hkust-gz.edu.cn) by the internal deadline.

    申报人填写指南建议模板,在校内截止时间前发送科研处联络人Alan Meng (邮箱: alanxmeng@hkust-gz.edu.cn)

    Enquiries 咨询

    孟熹 Alan Meng

    Research Department

    T: 020-8833 8992

    E: alanxmeng@ust.hk / alanxmeng@hkust-gz.edu.cn

    林宝珊 Bella Lin

    Research Department

    T: 020-8833 8993

    E: bellabslin@ust.hk / bellabslin@hkust-gz.edu.cn

    Supplementary Documents 相关附件